Gene · 4923
Papers2,119
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,119
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Synthesis of 64Cu-, 55Co-, and 68Ga-Labeled Radiopharmaceuticals Targeting Neurotensin Receptor-1 for Theranostics: Adjusting In Vivo Distribution Using Multiamine Macrocycles. | J Nucl Med | 2024 | 38871388 | PubTator, text mining | PubMed |
| Holistic concepts in GPCR dynamics. | Biophys Physicobiol | 2024 | 38803340 | PubTator, text mining | PubMed |
| Chelator boosted tumor-retention and pharmacokinetic properties: development of 64Cu labeled radiopharmaceuticals targeting neurotensin receptor. | Eur J Nucl Med Mol Imaging | 2024 | 38771516 | PubTator, text mining | PubMed |
| Insights on the G protein-coupled receptor helix 8 solution structure and orientation using a neurotensin receptor 1 peptide. | Protein Sci | 2024 | 38757374 | PubTator, text mining | PubMed |
| Development of a Fluorescent Ligand for the Intracellular Allosteric Binding Site of the Neurotensin Receptor 1. | ACS Pharmacol Transl Sci | 2024 | 38751637 | PubTator, text mining | PubMed |
| The prognostic value of lymph node to primary tumor standardized uptake value ratio in cancer patients: a meta-analysis. | Ann Nucl Med | 2024 | 38724805 | PubTator, text mining | PubMed |
| Neurotensin (8-13) and Neuromedin N Neuropeptides Radiolabelling with Copper-64 Produced on Solid or Liquid Targets. | Molecules | 2024 | 38543026 | PubTator, text mining | PubMed |
| Structural basis of human U5 snRNP late biogenesis and recycling. | Nat Struct Mol Biol | 2024 | 38467876 | PubTator, text mining | PubMed |
| Neuron-derived neurotensin promotes pancreatic cancer invasiveness and gemcitabine resistance via the NTSR1/Akt pathway. | Am J Cancer Res | 2024 | 38455426 | PubTator, text mining | PubMed |
| Structural effects of asymmetric magnet shape on performance of surface permanent magnet synchronous motors. | Sci Rep | 2024 | 38368472 | PubTator, text mining | PubMed |
| A novel investigation into the negative impact of opioid use on the efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients. | Int Immunopharmacol | 2024 | 38325047 | PubTator, text mining | PubMed |
| Nuclear-import receptors as gatekeepers of pathological phase transitions in ALS/FTD. | Mol Neurodegener | 2024 | 38254150 | PubTator, text mining | PubMed |
| Allosteric modulation of G protein-coupled receptors as a novel therapeutic strategy in neuropathic pain. | Acta Pharm Sin B | 2024 | 38239234 | PubTator, text mining | PubMed |
| Construction of a Lung Adenocarcinoma Prognostic Model Utilizing Serine and Glycine Metabolism-Related Genes. | J Proteome Res | 2024 | 38212294 | PubTator, text mining | PubMed |
| Causal effects of gut microbiota on sepsis and sepsis-related death: insights from genome-wide Mendelian randomization, single-cell RNA, bulk RNA sequencing, and network pharmacology. | J Transl Med | 2024 | 38167131 | PubTator, text mining | PubMed |
Integrating network pharmacology and transcriptomic omics reveals that akebia saponin D attenuates neutrophil extracellular traps-induced neuroinflammation via NTSR1/PKAc/PAD4 pathway after intracerebral hemorrhage. | FASEB J | 2024 | 38149910 | PubTator, text mining | PubMed |
| Construction of a prognostic model for lung adenocarcinoma based on m6A/m5C/m1A genes. | Hum Mol Genet | 2024 | 38142284 | PubTator, text mining | PubMed |
| Time-of-day-dependent variation of the human liver transcriptome and metabolome is disrupted in MASLD. | JHEP Rep | 2024 | 38125300 | PubTator, text mining | PubMed |
| Differential roles of serotonin receptor subtypes in regulation of neurotrophin receptor expression and intestinal hypernociception. | Histol Histopathol | 2024 | 38108436 | PubTator, text mining | PubMed |
| Significance of radiologic extranodal extension in locoregionally advanced nasopharyngeal carcinoma with lymph node metastasis: a comprehensive nomogram. | Braz J Otorhinolaryngol | 2024 | 38101121 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4923/papers?page=8